Cleerly LABS vs Vista OS
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary objective is to obtain a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) scans. This tool is ideal for clinicians who need to precisely detect, quantify, and characterize atherosclerosis and stenosis to inform personalized heart disease management and track disease progression over time.
View Cleerly LABS →Choose Vista OS if…
Choose Vista OS if your goal is to automate and streamline cardiac MRI acquisition, enhancing consistency, productivity, and patient access to high-quality imaging. This software is best suited for radiology departments or cardiology practices looking to optimize MRI workflow, reduce scan times, and ensure standardized image quality across their systems.
View Vista OS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Vista OS |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Cloud, On-premise | Vista AI Scan installs on customer-provided hardware and communicates directly with GE and Siemens MRI scanners. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Vista OSVista OS excels in usability by automating complex cardiac MRI acquisition tasks, making the workflow faster, easier, and more consistent for technologists of all skill levels. Customer testimonials highlight its ability to simplify scan planning and localization in 30 seconds, and provide an AI-driven toolkit for technologists. Cleerly LABS offers a rich diagnostic web-based user experience for clinicians, but Vista OS's direct impact on simplifying a highly technical acquisition process for a broader user base gives it an edge.
Clinical Value
Cleerly LABSCleerly LABS provides direct and comprehensive clinical value by detecting, quantifying, and characterizing atherosclerosis and stenosis from CCTA, aiding in personalized heart disease management and risk assessment. It offers detailed plaque assessment, stenosis quantification, and ischemia detection, directly informing diagnostic and prognostic decisions. While Vista OS enhances the consistency and quality of cardiac MRI acquisition, its value is in improving the input data, whereas Cleerly LABS delivers direct clinical interpretation and actionable insights.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing, with a retail price per analysis and information on potential insurance coverage, allowing for a clear assessment of its cost. In contrast, Vista OS does not publicly disclose its pricing, making it difficult for potential customers to evaluate its direct cost-effectiveness. While Vista OS promises significant operational efficiencies and increased patient throughput, the lack of pricing transparency makes it challenging to compare overall value directly.
Enterprise Readiness
Cleerly LABSCleerly LABS demonstrates strong enterprise readiness with explicit statements of HIPAA compliance and a Business Associate Agreement (BAA), alongside its cloud-based (AWS) deployment and integration capabilities with PACS, RIS, and EHR via an on-site proxy. While Vista OS is FDA-cleared and designed for multi-site deployment with secure remote access, its BAA and HIPAA compliance are not explicitly stated in the provided information, making Cleerly's offering appear more robust in terms of documented compliance and scalable architecture.
Innovation
Vista OSVista OS showcases a highly innovative approach by being the only third-party software cleared to directly control MRI systems for image acquisition and reconstruction, automating complex scan planning and real-time artifact detection. This directly addresses a critical bottleneck in radiology by simplifying and standardizing MRI scans, making high-quality imaging more accessible. While Cleerly LABS is innovative in CCTA interpretation, Vista OS's foundational automation of the imaging acquisition process itself represents a more disruptive innovation in workflow and resource utilization.
Support & Docs
Cleerly LABSCleerly LABS provides clear and accessible support information, including specific operating hours (Monday-Friday, 10 am ET to 6 pm ET) and a dedicated client support form for existing users. This level of detail offers transparency and assurance regarding ongoing assistance. Vista OS, while having general contact information, does not publicly provide specific support hours or a dedicated support portal for its medical device product, making its support structure less transparent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Vista OS |
|---|---|---|
| Tool Name | Cleerly LABS | Vista OS |
| Company | Cleerly | Vista AI, Inc. |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared, AI-powered software that automates and simplifies cardiac MRI acquisition, enhancing consistency, productivity, and patient access to high-quality imaging. |
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | Cardiac MRI |
| Key Feature Focus | Comprehensive coronary plaque assessment, stenosis detection, ischemia detection, personalized risk assessment, disease progression tracking. | Automated cardiac MRI acquisition, automated scan planning & localization, parameter tuning, real-time motion & artifact detection, in-line analysis. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Vista OS.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Vista OS
Backers
Who funded each tool's parent company.